Max Rosett Immunome Inc. (IMNM) insider trading activity
Max Rosett is Chief Financial Officer of Immunome Inc.. Currently has a direct ownership of 47,476 shares of IMNM, which is worth approximately $550,246. The most recent transaction as insider was on Sep 19, 2024, when has been sold 14,380 shares (Common Stock) at a price of $16.01 per share, resulting in proceeds of $230,223. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
47.5K
n/a
3M change
n/a
12M change
Total Value Held
$550,246
Max Rosett Transaction History
MR
Max Rosett
Chief Financial Officer
Exton, PA